- Home
- STOK vs ADV Comparison
STOK vs ADV Comparison
Compare STOK & ADV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- ADV
- Stock Information
- Founded
- STOK 2014
- ADV 1987
- Country
- STOK United States
- ADV United States
- Employees
- STOK N/A
- ADV N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- ADV Business Services
- Sector
- STOK Health Care
- ADV Consumer Discretionary
- Exchange
- STOK Nasdaq
- ADV Nasdaq
- Market Cap
- STOK 517.0M
- ADV 420.4M
- IPO Year
- STOK 2019
- ADV N/A
- Fundamental
- Price
- STOK $9.36
- ADV $1.47
- Analyst Decision
- STOK Strong Buy
- ADV Strong Buy
- Analyst Count
- STOK 5
- ADV 1
- Target Price
- STOK $27.50
- ADV $3.50
- AVG Volume (30 Days)
- STOK 813.9K
- ADV 376.6K
- Earning Date
- STOK 05-20-2025
- ADV 05-12-2025
- Dividend Yield
- STOK N/A
- ADV N/A
- EPS Growth
- STOK N/A
- ADV N/A
- EPS
- STOK N/A
- ADV N/A
- Revenue
- STOK $36,555,000.00
- ADV $3,566,324,000.00
- Revenue This Year
- STOK $27.80
- ADV N/A
- Revenue Next Year
- STOK $9.53
- ADV N/A
- P/E Ratio
- STOK N/A
- ADV N/A
- Revenue Growth
- STOK 316.34
- ADV N/A
- 52 Week Low
- STOK $5.35
- ADV $1.11
- 52 Week High
- STOK $17.58
- ADV $4.68
- Technical
- Relative Strength Index (RSI)
- STOK 57.94
- ADV 55.91
- Support Level
- STOK $8.30
- ADV $1.27
- Resistance Level
- STOK $10.12
- ADV $1.41
- Average True Range (ATR)
- STOK 0.59
- ADV 0.08
- MACD
- STOK -0.03
- ADV 0.04
- Stochastic Oscillator
- STOK 58.24
- ADV 96.36
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
About ADV Advantage Solutions Inc.
Advantage Solutions Inc is a omnichannel retail solutions agency in North America, uniquely positioned at the intersection of consumer-packaged goods (CPG) brands and retailers.